Ronald G Lafreniere

Title: Ronald G Lafreniere: Innovator in Epilepsy Research

Introduction

Ronald G Lafreniere is a notable inventor based in Verdun, Canada. He has made significant contributions to the field of epilepsy research, particularly through his innovative patent related to idiopathic generalized epilepsy.

Latest Patents

Lafreniere holds a patent titled "SCN3A locus for idiopathic generalized epilepsy, mutations thereof and method using same." This invention focuses on the identification of three genes mapping to chromosome 2 that exhibit mutations in patients with epilepsy. The patent encompasses nucleic acid sequences and protein sequences of these loci (SCNA) and their applications in assessing, diagnosing, prognosing, or treating epilepsy. Furthermore, it aims to predict an epileptic individual's response to medication and identify agents that modulate the function of the SCNA. The invention also includes screening assays using SCN1A, SCN2A, and/or SCN3A to identify compounds with therapeutic benefits for epilepsy and related neurological disorders.

Career Highlights

Throughout his career, Lafreniere has focused on advancing the understanding of epilepsy and its genetic underpinnings. His work has contributed to the development of new diagnostic and therapeutic strategies for individuals affected by this condition.

Collaborations

Lafreniere has collaborated with esteemed colleagues such as Guy A Rouleau and Daniel Rochefort. These partnerships have further enriched his research and expanded the impact of his inventions in the scientific community.

Conclusion

Ronald G Lafreniere's innovative work in epilepsy research exemplifies the importance of genetic studies in understanding and treating neurological disorders. His contributions continue to pave the way for advancements in medical science.